In vitro selection and analysis of human immunodeficiency virus Type 1 resistant to derivatives of β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine

被引：13

作者：

Hammond, JL

Parikh, UM

Koontz, DL

Schlueter-Wirtz, S

Chu, CK

Bazmi, HZ

Schinazi, RF

Mellors, JW

机构：

[1] Univ Pittsburgh, Sch Med, Div Infect Dis, Dept Med, Pittsburgh, PA 15261 USA

[2] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA

[3] Vet Affairs Med Ctr, Georgia VA Res Ctr AIDS & HIV Infect, Atlanta, GA 30033 USA

[4] Univ Georgia, Coll Pharm, Athens, GA 30602 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 09期

关键词：

D O I：

10.1128/AAC.49.9.3930-3932.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Serial passage of human immunodeficiency virus type 1 in MT-2 cells in increasing concentrations of the D-and L-enantiomers of beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine (d4FC) resulted in the selection of viral variants with reverse transcriptase substitutions M184I or M184V for L-d4FC and I63L, K65R, K70N, K70E, or R172K for D-d4FC. Phenotypic analysis of site-directed mutants defined the role of these mutations in reducing susceptibility to L- or D-d4FC.

引用

页码：3930 / 3932

页数：3

共 50 条

[41] INVITRO SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO 3'-AZIDO-3'-DEOXYTHYMIDINE
DIANZANI, F
ANTONELLI, G
TURRIZIANI, O
DONG, GM
CAPOBIANCHI, MR
RIVA, E
ANTIVIRAL RESEARCH, 1992, 18 (01) : 39 - 52
[42] 5-CHLORO-SUBSTITUTED DERIVATIVES OF 2',3'-DIDEHYDRO-2',3'-DIDEOXYURIDINE, 3'-FLUORO-2',3'-DIDEOXYURIDINE AND 3'-AZIDO-2',3'-DIDEOXYURIDINE AS ANTI-HIV AGENTS
BALZARINI, J
VANAERSCHOT, A
HERDEWIJN, P
DECLERCQ, E
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (06) : 869 - 874
[43] STRUCTURE OF (+)-(5R,6R)-5-CHLORO-6-METHOXY-5,6-DIHYDRO-1-(2',3'-DIDEHYDRO-2',3'-DIDEOXY-BETA-D-GLYCERO-2-ENOPENTOFURANOSYL)THYMINE
BLANCHARD, H
JAMES, MNG
KUMAR, R
WIEBE, LI
KNAUS, EE
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1993, 49 : 246 - 250
[44] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY PHOSPHONOFORMATE AND PHOSPHONOACETATE-2',3'-DIDEOXY-3'-THIACYTIDINE CONJUGATES
CHARVET, AS
CAMPLO, M
FAURY, P
GRACIET, JC
MOURIER, N
CHERMANN, JC
KRAUS, JL
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (14) : 2216 - 2223
[45] METABOLISM AND MODE OF SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION BY 3'-AZIDO-2',3'-DIDEOXY-5-IODOURIDINE AND 3'-AZIDO-2',3'-DIDEOXY-5-BROMOURIDINE
AUGUST, EM
QIAN, HY
BIRKS, EM
THOMBRE, UA
LIN, TS
PRUSOFF, WH
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (01) : 223 - 230
[46] Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidine
Medlin, HK
Zhu, YQ
Remington, KM
Phillips, TR
North, TW
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) : 953 - 957
[47] Cellular Pharmacology of the Anti-Hepatitis B Virus Agent β-L-2′,3′-Didehydro-2′,3′-Dideoxy-N4-Hydroxycytidine: Relevance for Activation in HepG2 Cells
Matthes, E.
Buenger, H.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) : 341 - 345
[48] SYNTHETIC NUCLEOSIDES AND NUCLEOTIDES .30. SYNTHESIS AND ANTIVIRAL ACTIVITY OF 3'-AZIDO, 2',3'-UNSATURATED AND 2',3'-DIDEOXY DERIVATIVES OF E-5-STYRYL-2'-DEOXYURIDINE ON HUMAN-IMMUNODEFICIENCY-VIRUS
YAMAGUCHI, T
SANEYOSHI, M
NUCLEOSIDES & NUCLEOTIDES, 1992, 11 (2-4): : 373 - 382
[49] POTENT AND SELECTIVE ANTI-HIV ACTIVITY OF 5-CHLORO-SUBSTITUTED DERIVATIVES OF 3'-AZIDO-2',3'-DIDEOXYCYTIDINE, 3'-FLUORO-2',3'-DIDEOXYCYTIDINE, AND 2',3'-DIDEHYDRO-2',3'-DIDEOXYCYTIDINE
BALZARINI, J
VANAERSCHOT, A
HERDEWIJN, P
DECLERCQ, E
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 616 : 480 - 482
[50] Determination of dosing guidelines for stavudine (2′,3′-didehydro-3′-deoxythymidine) in children with human immunodeficiency virus infection
Kaul, S
Kline, MW
Church, JA
Dunkle, LM
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 758 - 763

← 1 2 3 4 5 →